Sunday, June 26, 2011

A.M. Vitals: FDA Advisory Panel Votes Against Novartis?s Gout Drug

Also: statins and diabetes risk; Abbott wants to retool Humira; Merck KGaA throws in the towel on cladribine for MS.

Source: http://feedproxy.google.com/~r/wsj/health/feed/~3/bJ66k7H6Mak/

health migraines teeth hair

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)